Herbas VPB

Print
EN | LT
LT - Pakeistieji alifanai, ciklofanai, heterafanai, heterofanai, hetero-heterofanai ir metalocenai, tinkami panaudoti HCV infekcijų gydymui
EN - SUBSITUTED ALIPHANES, CYCLOPHANES, HETERAPHANES, HETEROPHANES, HETERO-HETERAPHANES AND METALLOCENES USEFUL FOR TREATING HCV INFECTIONS

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07F 17/02 (2006.01)
C07D 401/14 (2006.01)
C07D 403/14 (2006.01)
C07D 413/14 (2006.01)
C07D 417/14 (2006.01)
C07D 471/08 (2006.01)
C07D 471/14 (2006.01)
C07D 491/10 (2006.01)
C07D 519/00 (2006.01)
A61K 31/4178 (2006.01)
A61K 31/4164 (2006.01)
A61P 31/00 (2006.01)
A61P 31/12 (2006.01)
European patent
(11) Number of the document 2714036
(13) Kind of document T
(96) European patent application number 12793566.6
Date of filing the European patent application 2012-05-29
(97) Date of publication of the European application 2014-04-09
(45) Date of publication and mention of the grant of the patent 2016-06-22
(46) Date of publication of the claims translation 2016-10-10
PCT application
(86) Number PCT/US2012/039835
Date 2012-05-29
PCT application publication
(87) Number WO 2012/166716
Date 2012-12-06
Priority applications
(30) Number Date Country code
201161490881 P 2011-05-27 US
201161504905 P 2011-07-06 US
201161567216 P 2011-12-06 US
Inventors
(72)
WILES, Jason Allan, US
WANG, Qiuping, US
HASHIMOTO, Akihiro, US
PAIS, Godwin, US
CHEN, Dawei, US
WANG, Xiangzhu, US
GADHACHANDA, Venkat, US
PHADKE, Avinash, US
DESHPANDE, Milind, US
Grantee
(73) Achillion Pharmaceuticals, Inc., 300 George Street, New Haven, CT 06511, US
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Pakeistieji alifanai, ciklofanai, heterafanai, heterofanai, hetero-heterofanai ir metalocenai, tinkami panaudoti HCV infekcijų gydymui
  SUBSITUTED ALIPHANES, CYCLOPHANES, HETERAPHANES, HETEROPHANES, HETERO-HETERAPHANES AND METALLOCENES USEFUL FOR TREATING HCV INFECTIONS
Last renewal fee
Payment date Validity (years) Amount
2018-05-22 7 162.00 EUR
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2019-05-29